March 19, 2025

Immunovant Will Drop One Myasthenia Gravis Asset, Continuing to Favor Another – BioSpace

March 15, 2025

FDA Approves Expanded Indication of Eculizumab for Pediatric Generalized Myasthenia Gravis – AJMC

March 13, 2025

Amgen’s Uplizna Deepens Response Against Myasthenia Gravis at 1 Year – BioSpace

March 12, 2025

FDA Approves Expanded Indication of Eculizumab for Pediatric Generalized Myasthenia Gravis – Pharmacy Times

March 11, 2025

FDA OKs First Myasthenia Gravis Treatment for Children – WebMD